We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

215 hedge funds and large institutions have $2.47B invested in Arena Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

60% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 43

31% more capital invested

Capital invested by funds: $1.88B → $2.47B (+$586M)

19% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $16.4M

17% more funds holding

Funds holding: 184 → 215 (+31)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
215
Holders Change
+31
Holders Change %
+16.85%
% of All Funds
4.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
58
Increased
69
Reduced
43
Closed
23
Calls
$19.5M
Puts
$16.4M
Net Calls
+$3.06M
Net Calls Change
-$6.54M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
2
N
Nuveen
North Carolina
+$23.4M
3
EMG
ETF Managers Group
New Jersey
+$20.9M
4
Invesco
Invesco
Georgia
+$11.2M
5
MCM
Matarin Capital Management
New York
+$10.7M

Top Sellers

1
PHS
PFM Health Sciences
California
-$73.7M
2
RCMNY
Rubric Capital Management (New York)
New York
-$38.4M
3
Citadel Advisors
Citadel Advisors
Florida
-$16.7M
4
MWNA
Marshall Wace North America
New York
-$16.5M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
26
VOYA Investment Management
Georgia
$23.2M -$5.2M -100,598 -20%
EMFAT
27
Emerald Mutual Fund Advisers Trust
Pennsylvania
$22.8M – – –
Charles Schwab
28
Charles Schwab
California
$19.7M +$2.62M +50,778 +18%
CS
29
Candriam SCA
Luxembourg
$16.5M – – –
MWNA
30
Marshall Wace North America
New York
$15.9M -$16.5M -318,601 -54%
ACM
31
Atika Capital Management
New York
$13.5M +$1.81M +35,000 +18%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$13.4M +$670K +12,961 +6%
Invesco
33
Invesco
Georgia
$13.1M +$11.2M +217,643 +3,642%
Deutsche Bank
34
Deutsche Bank
Germany
$12.5M -$2.17M -41,916 -16%
American Century Companies
35
American Century Companies
Missouri
$12.4M +$4.3M +83,163 +65%
MCM
36
Matarin Capital Management
New York
$12.1M +$10.7M +206,610 New
Axa
37
Axa
France
$11.9M +$211K +4,088 +2%
CAM
38
Cormorant Asset Management
Massachusetts
$11.7M -$2.58M -50,000 -20%
Adage Capital Partners
39
Adage Capital Partners
Massachusetts
$11.1M – – –
Bank of America
40
Bank of America
North Carolina
$11.1M +$2.26M +43,663 +30%
RPAM
41
Rhenman & Partners Asset Management
Sweden
$9.97M -$3.34M -64,558 -28%
Man Group
42
Man Group
United Kingdom
$9.81M +$2.7M +52,158 +45%
PM
43
Prosight Management
Texas
$9.63M -$4.56M -88,200 -35%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$9.36M +$5.99M +115,923 +265%
Federated Hermes
45
Federated Hermes
Pennsylvania
$8.99M +$3.07M +59,457 +63%
Wells Fargo
46
Wells Fargo
California
$8.59M +$3.63M +70,175 +92%
JP Morgan Chase
47
JP Morgan Chase
New York
$6.96M -$143K -2,759 -2%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$6.82M +$2.47M +47,755 +70%
Prudential Financial
49
Prudential Financial
New Jersey
$6.46M -$694K -13,437 -11%
O
50
OrbiMed
New York
$6.45M +$5.69M +110,000 New
1
2
3 4 5

ARNA Hedge Fund Activity: Q2 2019 in Review

215 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2019, worth a combined $2.47B — up 31% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ARNA positions and 23 closed out — a net gain of 35 holders — while 69 added to existing stakes and 43 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $50.6M. The largest seller was PFM Health Sciences, cutting an estimated $73.7M.

  • 215 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2019, up from 184 in Q1 2019.
  • Funds reported $2.47B of Arena Pharmaceuticals Inc stock for Q2 2019, up 31% quarter-over-quarter.
  • 58 funds opened new Arena Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of +35 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2019 was AllianceBernstein, an estimated $50.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2019 was PFM Health Sciences, an estimated $73.7M sold.

Based on aggregated 13F filings for Q2 2019.